Women & Minority-Owned BioAI
NIH / NIAID SBIR-ready
SBIR Portal: PromptGenix BioAI Automation Platform
This portal is a reviewer-friendly hub for PromptGenix Phase I materials. Navigate to Specific Aims, Research Strategy (Approach), Commercialization, Facilities & Environment, Company/Team, and Use Cases. All Phase I validation is planned using public datasets only.
Contact: dohoon.kim1@icloud.com
· PromptGenix LLC · Women & Minority-Owned Small Business
Quick summary
What PromptGenix does in Phase I
Automates RNA-Seq and flow cytometry pipelines into reproducible outputs and produces ranked, testable hypotheses with suggested experiments grounded in observed signals and citations.
Automation
Reproducibility
Hypothesis Generator
Public-data validation
Portal contents
Open the section you need (one click).
Each page is designed to be readable in a browser and printable to PDF for submission workflows.
SBIR Overview
Problem, innovation, Phase I focus, and why it matters.
Specific Aims
Significance, innovation, objective/hypothesis, aims, expected outcomes.
Research Strategy – Approach
Phase I workflow, validation plan, KPIs, and Risks & Mitigation.
Commercialization
Customers, value proposition, differentiation, business model, milestones.
Facilities & Environment
Local compute + cloud-ready path supporting Phase I deliverables.
Company / Team
Women-led operations + founder-led technical execution (Phase I readiness).
Use Cases
Example artifacts for RNA-Seq, NGS automation, flow cytometry, and hypotheses.
Reviewer note: This portal is intentionally scoped to Phase I feasibility and validation using public datasets
(GEO/SRA/FlowRepository). Sensitive partner data and IP are not required for Phase I proof.